TY - JOUR
T1 - Resilience in women with autoimmune rheumatic diseases
AU - Rojas, Manuel
AU - Rodriguez, Yhojan
AU - Pacheco, Yovana
AU - Zapata, Elizabeth
AU - Monsalve, Diana M.
AU - Mantilla, Rubén D.
AU - Rodríguez-Jimenez, Monica
AU - Ramírez-Santana, Carolina
AU - Molano-González, Nicolás
AU - Anaya, Juan Manuel
N1 - Funding Information:
This work was supported by Universidad del Rosario (ABN011) and Colciencias (Grant No 122254531722 /Grant No 0425-2013 ), Bogota, Colombia.
Publisher Copyright:
© 2017 Société française de rhumatologie
Copyright:
Copyright 2019 Elsevier B.V., All rights reserved.
PY - 2018/12
Y1 - 2018/12
N2 - Objective: To evaluate the relationship between resilience and clinical outcomes in patients with autoimmune rheumatic diseases. Methods: Focus groups, individual interviews, and chart reviews were done to collect data on 188 women with autoimmune rheumatic diseases, namely rheumatoid arthritis (n = 51), systemic lupus erythematosus (n = 70), systemic sclerosis (n = 35), and Sjögren's syndrome (n = 32). Demographic, clinical, and laboratory variables were assessed including disease activity by patient reported outcomes. Resilience was evaluated by using the Brief Resilience Scale. Bivariate, multiple linear regression, and classification and regression trees were used to analyse data. Results: Resilience was influenced by age, duration of disease, and socioeconomic status. Lower resilience scores were observed in younger patients (< 48 years) with systemic lupus erythematosus, rheumatoid arthritis, and systemic sclerosis who had low socioeconomic status, whereas older patients (> 50 years) had higher resilience scores regardless of socioeconomic status. There was no influence of disease activity on resilience. A particular behaviour was observed in systemic sclerosis in which patients with high socioeconomic status and regular physical activity had higher resilience scores. Conclusion: Resilience in patients with autoimmune rheumatic diseases is a continuum process influenced by age and socioeconomic status. The ways in which these variables along with exercise influence resilience deserve further investigation.
AB - Objective: To evaluate the relationship between resilience and clinical outcomes in patients with autoimmune rheumatic diseases. Methods: Focus groups, individual interviews, and chart reviews were done to collect data on 188 women with autoimmune rheumatic diseases, namely rheumatoid arthritis (n = 51), systemic lupus erythematosus (n = 70), systemic sclerosis (n = 35), and Sjögren's syndrome (n = 32). Demographic, clinical, and laboratory variables were assessed including disease activity by patient reported outcomes. Resilience was evaluated by using the Brief Resilience Scale. Bivariate, multiple linear regression, and classification and regression trees were used to analyse data. Results: Resilience was influenced by age, duration of disease, and socioeconomic status. Lower resilience scores were observed in younger patients (< 48 years) with systemic lupus erythematosus, rheumatoid arthritis, and systemic sclerosis who had low socioeconomic status, whereas older patients (> 50 years) had higher resilience scores regardless of socioeconomic status. There was no influence of disease activity on resilience. A particular behaviour was observed in systemic sclerosis in which patients with high socioeconomic status and regular physical activity had higher resilience scores. Conclusion: Resilience in patients with autoimmune rheumatic diseases is a continuum process influenced by age and socioeconomic status. The ways in which these variables along with exercise influence resilience deserve further investigation.
UR - http://www.scopus.com/inward/record.url?scp=85040667107&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85040667107&partnerID=8YFLogxK
U2 - 10.1016/j.jbspin.2017.12.012
DO - 10.1016/j.jbspin.2017.12.012
M3 - Research Article
C2 - 29289647
AN - SCOPUS:85040667107
SN - 1297-319X
VL - 85
SP - 715
EP - 720
JO - Joint Bone Spine
JF - Joint Bone Spine
IS - 6
ER -